On Monday, Sage Therapeutics Inc (NASDAQ: SAGE) was 35.37% up from the session before settling in for the closing price of $6.70. A 52-week range
Sage Therapeutics Inc (NASDAQ: SAGE) started the day on Thursday, with a price increase of 3.67% at $6.78, before settling in for the price of
Sage Therapeutics Inc (NASDAQ: SAGE) flaunted slowness of -4.63% at $6.80, as the Stock market unbolted on Wednesday, before settling in for the price of
Sage Therapeutics Inc (NASDAQ: SAGE) kicked off on Friday, up 4.24% from the previous trading day, before settling in for the closing price of $6.61.
During the past 52 weeks, Sage Therapeutics (SAGE) shares have fallen about 25%. Another reason for the decline in quotations is the drug’s inability to
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.